Stable supply system of 3 plants with high production capacity

Towa has total of 11.5 billion tablets with 3 plants combined, Osaka, Okayama, and Yamagata Plant.
We have additional space in the building which we can manufacture up to 14 billion tablets. We are now constructing a system to boost our manufacturing capacity to cope with the increasing demand. For the purpose of the stable supply of Towa’s products, the products of oral formulations are separated in 3 portions, and each portion is allocated to 1 of the plants, respectively. On the other hand, injectable are manufactured only at a building with quake-absorbing structure in Yamagata Plant. These measures and policies minimize the disaster risk. The 3 plants in compliance with PIC/S GMP achieve high quality and stable supply of products and to support the future with trust.
Osaka plant serves as a tablet technology plant responsible for introducing new products with general formulations, while Okayama plant serves as a mass production technology plant for handling various products including capsules, powders, and granules. Yamagata plant serves as a comprehensive technology plant handling solid formulations, sterile formulations, and their high potent active pharmaceuticals.

3 Plants Overview

Osaka Plant

Manufacturing Capacity	2.5 billion
Manufacturing Capabilities	Tablets

Okayama Plant

Manufacturing Capacity	5 billion
Manufacturing Capabilities	Tablets, Powder, Granules, Capsules

Yamagata Plant

Manufacturing Capacity	4 billion（Up to 6.5 billion can be produced）
Manufacturing Capabilities	Tablets, Powders, Granules, Capsules, Injections

Injections are manufactured only at a building of quake-absorbing structure in Yamagata Plant.